Hexagon Capital Partners’s Globus Medical GMED Stock Holding History

Hexagon Capital Partners’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-102	Closed	-$7.47K	–	728
2025 Q1	$7.47K	Hold	102	–	–	﹤0.01%	1059
2024 Q4	$8.44K	Hold	102	–	–	﹤0.01%	1066
2024 Q3	$7.3K	Hold	102	–	–	﹤0.01%	993
2024 Q2	$6.99K	Hold	102	–	–	﹤0.01%	947
2024 Q1	$5.47K	Hold	102	–	–	﹤0.01%	979
2023 Q4	$5.44K	Sell	102 -15	-13%	-$731	﹤0.01%	958
2023 Q3	$5.81K	Buy	117 +17	+17%	+$951	﹤0.01%	880
2023 Q2	$5.95K	Hold	100	–	–	﹤0.01%	865
2023 Q1	$5.66K	Hold	100	–	–	﹤0.01%	869
2022 Q4	$7.43K	Hold	100	–	–	﹤0.01%	810
2022 Q3	$6K	Hold	100	–	–	﹤0.01%	892
2022 Q2	$6K	Hold	100	–	–	﹤0.01%	758
2022 Q1	$7K	Hold	100	–	–	﹤0.01%	666
2021 Q4	$7K	Hold	100	–	–	﹤0.01%	637
2021 Q3	$8K	Hold	100	–	–	﹤0.01%	617
2021 Q2	$8K	Hold	100	–	–	﹤0.01%	582
2021 Q1	$6K	Hold	100	–	–	﹤0.01%	575
2020 Q4	$6K	Hold	100	–	–	﹤0.01%	538
2020 Q3	$5K	Buy	+100	New	+$5.16K	﹤0.01%	530

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Hexagon Capital Partners's GMED Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 102 shares — an estimated $7.47K sold.

Hexagon Capital Partners first reported a position in GMED in Q3 2020 and held it in 19 quarters. The position peaked at $8.44K in Q4 2024. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

Hexagon Capital Partners reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
Hexagon Capital Partners sold 102 Globus Medical shares in Q2 2025, an estimated $7.47K.
Hexagon Capital Partners first reported a position in Globus Medical in Q3 2020 and held it in 19 quarters.
Hexagon Capital Partners's Globus Medical position peaked at $8.44K in Q4 2024.
480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.